A new target for differentiation therapy in AML

Simple item page
dc.contributor.authorMa, Peilin
dc.contributor.authorSong, Weihua
dc.contributor.authorHess, Jay L.
dc.contributor.departmentPathology and Laboratory Medicine, School of Medicineen_US
dc.date.accessioned2018-05-29T12:29:55Z
dc.date.available2018-05-29T12:29:55Z
dc.date.issued2017-01
dc.description.abstractDespite major advances in understanding the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are beginning to identify promising new therapeutic targets.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationMa, P., Song, W., & Hess, J. L. (2017). A new target for differentiation therapy in AML. Cell Research, 27(1), 9–10. http://doi.org/10.1038/cr.2016.130en_US
dc.identifier.urihttps://hdl.handle.net/1805/16271
dc.language.isoen_USen_US
dc.publisherSpringer Natureen_US
dc.relation.journalCell Researchen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectGeneticsen_US
dc.subjectEpigeneticsen_US
dc.subjectAcute myeloid leukemiaen_US
dc.subjectCancer -- Differentiation therapyen_US
dc.titleA new target for differentiation therapy in AMLen_US
dc.typeArticleen_US
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223225/en_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
cr2016130a(1).pdf
Size:
840.87 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Pathology and Laboratory Medicine Works
Jay L. Hess